carbamates has been researched along with fluticasone furoate in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Ambery, C; Daley-Yates, P; Riddell, K | 1 |
| Ambery, C; Daley-Yates, P; Fuller, T; Georgiou, A; Puri, A; Ramsay, D; Young, G | 1 |
| Baidoo, C; Castro-Santamaria, R; Crawford, C; Crim, C; Emmett, A; Gotfried, M; Spangenthal, S; Watkins, M | 1 |
3 trial(s) available for carbamates and fluticasone furoate
| Article | Year |
|---|---|
Open-Label, Randomized, 6-Way Crossover, Single-Dose Study to Determine the Pharmacokinetics of Batefenterol (GSK961081) and Fluticasone Furoate When Administered Alone or in Combination.
Topics: Administration, Inhalation; Adolescent; Adult; Androstadienes; Area Under Curve; Bronchodilator Agents; Carbamates; Cross-Over Studies; Drug Combinations; Dry Powder Inhalers; Female; Humans; Male; Middle Aged; Quinolones; Young Adult | 2016 |
Open-Label, Crossover Study to Determine the Pharmacokinetics of Fluticasone Furoate and Batefenterol When Administered Alone, in Combination, or Concurrently.
Topics: Adult; Androstadienes; Area Under Curve; Carbamates; Cross-Over Studies; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Female; Healthy Volunteers; Humans; Male; Middle Aged; Quinolones; Young Adult | 2019 |
A randomized, controlled, repeat-dose study of batefenterol/fluticasone furoate compared with placebo in the treatment of COPD.
Topics: Administration, Inhalation; Aged; Androstadienes; Carbamates; Double-Blind Method; Drug Combinations; Female; Forced Expiratory Volume; Humans; Male; Middle Aged; Nebulizers and Vaporizers; Pulmonary Disease, Chronic Obstructive; Quinolones; Treatment Outcome | 2020 |